Digi Yatra May Become Indias Digital Identity Layer Beyond Aviation Dycom Shares Surge as Earnings and Revenue Accelerate on Data Center Acquisitions Tax Season 2025 New Rules for Online Sellers and EV Buyers Could Offer Savings SpaceX Goes Public The Critical Milestone for a Potential 15 Trillion Valuation Longevity Biotech Stocks Rise Amid 27 Trillion Healthcare Shift Toward Cell Restoration Top Five Triggers Including RBI Dividend and USIran Tensions That Could Shape Indian Stock Market This Week LOAR Q1 2026 Earnings EPS Surges 1087 Above Estimates Stock Edges Lower MTB Q1 2026 Earnings Earnings Beat Estimates as Net Interest Income Holds Steady Annovis Bio Q1 2026 Earnings EPS Misses Estimates as PreClinical Spending Intensifies EFOI Q4 2024 Earnings Narrowed Loss Amid Continued Strategic Restructuring Intergroup Corporation INTG Q1 2026 Earnings Positive EPS as Stock Advances Despite Sparse Disclosure Auddia Inc AUUD Q1 2025 Earnings EPS Misses Estimates by a Wide Margin Amid No Revenue SouthState Bank SSB Edges Higher as Price Holds Above Key Support Kestrel Group Ltd KG Faces Selling Pressure Testing Key Support Levels Scienture Holdings SCNX Faces Selling Pressure Near Key Support Level Hongli Group HLP Faces Resistance Near 050 as Stock Slips by 095 QVCD Holds Steady at 1010 as Bond Market Navigates Mixed Signals Jim Cramer Highlights Xometrys Growth What It Signals for the Manufacturing Marketplace AGCO Q1 2026 Earnings Strong Profit Beat Bolsters Investor Sentiment After Challenging Quarter Acme United Corporation ACU Shows Modest Uptick Amid RangeBound Trading EICC Q4 2025 Earnings Marginal EPS Miss Amid Stable Preferred Stock Performance Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Stock Gains Slightly Katapult Holdings Q1 2026 Earnings Massive Profitability Surprise Drives DoubleDigit EPS Beat Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline SCNX Q1 2026 Earnings Strong EPS Beat Driven by Cost Management Guardant Health Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares DTIL Q1 2026 Earnings EPS Misses Estimates as Gene Editing Pipeline Progress Takes Center Stage